DUBLIN--(BUSINESS WIRE)--The "Global Topical Drug Delivery Market - Growth, Trends, and Forecasts (2017 - 2022)" report has been added to Research and Markets' offering.
Topical administration means drug delivery via application on body surfaces, such as the skin or mucus membranes, including nasal sprays and ophthalmic drops.
The market is majorly driven by increased patient compliance, owing to the potential for self and painless administration. High incidence of skin diseases like eczema, psoriasis, etc. and minor ailments like acne contribute to the market expansion. High initial capital requirements, presence of strict regulatory framework, and frequent product recalls like Philips' voluntary recall of topical antibiotic products in June, 2017 are affecting growth.
The global topical drug delivery market has been segmented, based on the routes of administration (dermal, ophthalmic, nasal, oral topical, vaginal, and others), by products (Formulation- Solid, Semi-solid and liquid devices) and by region (North America, Europe, Asia-Pacific, Middle East and Africa, South America)
The report provides a detailed overview of each type of topical drug delivery method, along with an in-depth analysis, in addition to the company profiles of major players in the space and a clear picture of a competitive landscape that currently exists in the market.
Companies Mentioned
- Glaxosmithkline
- Galderma
- Bayer
- Valeant Pharmaceuticals
- Novartis
- Medpharm
- Hisamitsu Pharmaceuticals
- Johnson & Johnson
- Crescita Therapeutics
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/z43vrn/global_topical
